Sarglamides A–E, Indolidinoid-Monoterpenoid Hybrids with Anti-Neuroinflammatory Activity from a Sarcandra Species

18 January 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Sarglamides A–E (1−5), representing the first example of heterodimers of a trans-N-cinnamoylindolidinoid and an α-phelladrene derivatives, were isolated from Sarcandra glabra subsp. brachystachys. Particularly, compounds 4 and 5 possess unprecedented cage-like 6/6/5/6/5- and 6/6/6/6/5-fused pentacyclic scaffolds, respectively. Their structures were established by spectroscopic analysis, X-ray crystallography, quantum chemical calculations, and chemical conversions. Plausible biosynthetic pathways of 1−5, involving the co-isolated enantiomers 6a and 6b were proposed. Compounds 3–7 showed inhibitory activity against lipopolysaccharide (LPS) induced inflammation in BV-2 microglial cells.


Sarcandra glabra subsp. brachystachys
Indolidinoid-monoterpenoid hybrids
Novel skeletons
Structural elucidation
Anti-neuroinflammatory activity

Supplementary materials

Supplementary Materials
Experimental section, computational section, synthesis section, biological evaluation part, spectroscopic data including IR, MS, and NMR spectra for compounds 1−7


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.